We are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world.
Orchard Pharmaceuticals Company , Inc plays a role in developing single tablet regimens – with one pill once a day, patients can take all of their medication in each dose.
Our scientists are applying new knowledge about how Ebola grow and spread to potentially enhance and improve Ebola therapy.
Our liver disease programs focus on expanding treatment options for chronic hepatitis B and C.
Our medicines aim to help patients with cardiovascular disease return to their daily activities, and we are exploring potential new indications.